We are live on ! Find out more
Los Angeles Capital Management

Los Angeles Capital Management Portfolio holdings

AUM $27.2B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
Cap. Flow
-$77.1M
Cap. Flow %
-0.4%
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234

Sector Composition

Rank Sector Weight
1 Technology 31.43%
2 Healthcare 14.49%
3 Financials 11.62%
4 Consumer Discretionary 10.92%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALM icon
926
Cal-Maine
CALM
$3.91B
$512K ﹤0.01%
9,203
-42,537
-82% -$2.33M
STBA icon
927
S&T Bancorp
STBA
$1.82B
$511K ﹤0.01%
17,440
+560
+3% +$16.8K
CACI icon
928
CACI
CACI
$14.9B
$504K ﹤0.01%
1,931
-573
-23% -$161K
TWST icon
929
Twist Bioscience
TWST
$7.81B
$503K ﹤0.01%
14,286
+7,727
+118% +$328K
HTB
930
HomeTrust Bancshares
HTB
$836M
$502K ﹤0.01%
22,700
AMSF icon
931
AMERISAFE
AMSF
$515M
$501K ﹤0.01%
10,720
-7,141
-40% -$345K
CBNK icon
932
Capital Bancorp
CBNK
$615M
$497K ﹤0.01%
21,495
+2,839
+15% +$67.9K
HLX icon
933
Helix Energy Solutions
HLX
$1.5B
$496K ﹤0.01%
+128,380
New +$487K
X
934
DELISTED
US Steel
X
$496K ﹤0.01%
+27,350
New +$585K
SFM icon
935
Sprouts Farmers Market
SFM
$7.8B
$492K ﹤0.01%
17,730
+211
+1% +$5.99K
BRKL
936
DELISTED
Brookline Bancorp
BRKL
$485K ﹤0.01%
41,595
-16,277
-28% -$215K
HWKN icon
937
Hawkins
HWKN
$2.74B
$484K ﹤0.01%
12,424
BAP icon
938
Credicorp
BAP
$29.7B
$477K ﹤0.01%
3,881
+2,025
+109% +$260K
BY icon
939
Byline Bancorp
BY
$1.78B
$474K ﹤0.01%
23,390
CELH icon
940
Celsius Holdings
CELH
$7.09B
$474K ﹤0.01%
15,693
+3,192
+26% +$100K
UTMD icon
941
Utah Medical Products
UTMD
$228M
$472K ﹤0.01%
5,537
GNRC icon
942
Generac Holdings
GNRC
$13.1B
$470K ﹤0.01%
+2,640
New +$605K
TROW icon
943
T. Rowe Price
TROW
$23.5B
$470K ﹤0.01%
4,473
-67,058
-94% -$8M
PLUS icon
944
ePlus
PLUS
$2.3B
$469K ﹤0.01%
11,291
-3,900
-26% -$191K
DVAX
945
DELISTED
Dynavax Technologies
DVAX
$468K ﹤0.01%
44,831
+28,224
+170% +$368K
ARWR icon
946
Arrowhead Research
ARWR
$12.3B
$466K ﹤0.01%
14,109
+1,401
+11% +$56.5K
PFS icon
947
Provident Financial Services
PFS
$3.26B
$466K ﹤0.01%
23,906
-15,100
-39% -$353K
LPRO
948
DELISTED
Open Lending Corp
LPRO
$460K ﹤0.01%
57,230
+36,495
+176% +$369K
STEM icon
949
Stem
STEM
$55.1M
$460K ﹤0.01%
1,724
+652
+61% +$167K
CARE icon
950
Carter Bankshares
CARE
$760M
$457K ﹤0.01%
28,367

Similar funds

Los Angeles Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
  • Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
  • Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
  • Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
  • Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
  • Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
  • Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.

Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.